23andMe And Genentech Plan To Do Parkinson’s Research

January 8, 2015 3:15 PM

15 0

Biotech powerhouse Genentech Inc. and 23andMe INC will work together to find potential new treatments for Parkinson’s disease.

In the new partnership, Genentech will sequence the whole genome of about 3,000 people with Parkinson’s disease in 23andMe’s database, and use that data to look for new therapeutic targets. These new therapeutic targets could then be used to create treatments to treat the neurodegenerative condition...

Read more

To category page